Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 Inhibitors

(MedPage Today) — Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization’s updated clinical practice guideline.
In a synopsis of the recently published guideline — serving…